Clover Health Investments (CLOV) Operating Income (2019 - 2026)

Clover Health Investments has reported Operating Income for 8 years, with the latest figure at $27.3 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Income rose 2245.53% year-over-year to $27.3 million; the trailing twelve-month figure through Mar 2026 stood at -$56.9 million (down 134.05% YoY), and the FY2025 full-year result was -$85.5 million, down 86.95% from the prior year.
• Operating Income for Q1 2026 stood at $27.3 million, up from -$49.3 million in the prior quarter.
• The five-year high for Operating Income was $27.3 million in Q1 2026, with the low at -$102.7 million in Q2 2022.
• Historically, Operating Income has averaged -$35.1 million across 5 years, with a median of -$24.4 million in 2025.
• Annual changes were most pronounced in 2025 — Operating Income sank 246.92% — and 2026, when it soared 2245.53%.
• Clover Health Investments' Operating Income stood at -$22.4 million in 2022, then tumbled by 182.35% to -$63.1 million in 2023, then soared by 66.03% to -$21.4 million in 2024, then tumbled by 129.95% to -$49.3 million in 2025, then jumped by 155.42% to $27.3 million in 2026.
• The last three Operating Income figures came in at $27.3 million (Q1 2026), -$49.3 million (Q4 2025), and -$24.4 million (Q3 2025), per Business Quant data.